RCEL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RCEL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
AVITA Medical has the Financial Strength Rank of 3. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.
Warning Sign:
AVITA Medical Inc displays poor financial strength. Usually, this is caused by too much debt for the company.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.AVITA Medical did not have earnings to cover the interest expense. AVITA Medical's debt to revenue ratio for the quarter that ended in Sep. 2024 was 0.58. As of today, AVITA Medical's Altman Z-Score is -3.68.
For the Medical Devices subindustry, AVITA Medical's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Financial Strength distribution charts can be found below:
* The bar in red indicates where AVITA Medical's Financial Strength falls into.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
AVITA Medical's Interest Expense for the months ended in Sep. 2024 was $-1.36 Mil. Its Operating Income for the months ended in Sep. 2024 was $-13.81 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $45.63 Mil.
AVITA Medical's Interest Coverage for the quarter that ended in Sep. 2024 is
AVITA Medical did not have earnings to cover the interest expense. |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
AVITA Medical's Debt to Revenue Ratio for the quarter that ended in Sep. 2024 is
Debt to Revenue Ratio | = | Total Debt (Q: Sep. 2024 ) | / | Revenue | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Revenue | |
= | (0 | + | 45.626) | / | 78.184 | |
= | 0.58 |
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
AVITA Medical has a Z-score of -3.68, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
Warning Sign:
Altman Z-score of -3.68 is in distress zone. This implies bankruptcy possibility in the next two years.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVITA Medical (NAS:RCEL) Financial Strength Explanation
The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.
AVITA Medical has the Financial Strength Rank of 3. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.
Thank you for viewing the detailed overview of AVITA Medical's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.
David D O'toole | officer: CFO | 1640 MARENGO STREET, LOS ANGELES CA 90033 |
James Corbett | director | 2 GOODYEAR, IRVINE CA 92618 |
Jeremy Curnock Cook | director | TARGETED GENETICS CORP, 1100 OLIVE WAY STE 100, SEATTLE WA 98101 |
Donna Shiroma | officer: General Counsel | C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355 |
Cary Guy Vance | director | 800 EAST MIDDLEFIELD RD, MOUNTAIN VIEW CA 94043 |
Robert Mcnamara | director | C/O LDR HOLDING CORPORATION, 13785 RESEARCH BOULEVARD, SUITE 200, AUSTIN TX 78750 |
Michael S Perry | director, officer: Chief Executive Officer | C/O BIOTRANSPLANT INC, 196 BOSTON AVE SUITE 2800, MEDFORD MA 02155 |
Suzanne Crowe | director | C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355 |
Jan Stern Reed | director | C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015 |
Michael Holder | officer: Chief Financial Officer | 6170 RESEARCH RD., STE 103, FRISCO TX 75034 |
Kathy M. Mcgee | officer: Chief Operating Officer | C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355 |
Sean Ekins | officer: Sr. VP of Finance | C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355 |
David Mcintyre | officer: Chief Financial Officer | SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000 |
Damien Mcdonald | director | 5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON X0 W21AY |
Erin Liberto | officer: Chief Commercial Officer | C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355 |
From GuruFocus
By GuruFocus News • 11-08-2024
By GuruFocus News • 11-19-2024
By Marketwired • 05-30-2024
By GuruFocus Research • 09-14-2024
By GuruFocus Research • 09-23-2024
By Marketwired • 05-16-2024
By Marketwired • 11-12-2024
By Marketwired • 11-08-2024
By Marketwired • 11-25-2024
By Marketwired • 04-15-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.